Antidepressant use in pregnancy and the risk of cardiac defects - Wikidata - thesis-toulmin - TriplyDB

Antidepressant use in pregnancy and the risk of cardiac defects

Antidepressant use in pregnancy and the risk of cardiac defects

http://www.wikidata.org/entity/Q33775616

about

The Risk of Congenital Heart Anomalies Following Prenatal Exposure to Serotonin Reuptake Inhibitors-Is Pharmacogenetics the Key?Optimizing the treatment of mood disorders in the perinatal period Paroxetine-The Antidepressant from Hell? Probably Not, But Caution Required Constructing Causal Diagrams for Common Perinatal Outcomes: Benefits, Limitations and Motivating Examples with Maternal Antidepressant Use in Pregnancy Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data.P-values and decision-making: discussion of 'Limitations of empirical calibration of p-values using observational data'.Links between serotonin reuptake inhibition during pregnancy and neurodevelopmental delay/spectrum disorders: A systematic review of epidemiological and physiological evidence.Treating perinatal depression: risks and stigma.Early pregnancy exposure to selective serotonin reuptake inhibitors, risks of major structural malformations, and hypothesized teratogenic mechanisms.Depression and antidepressants in pregnancy: molecular and psychosocial mechanisms affecting offspring's physical and mental health Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants Statins and congenital malformations: cohort study Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design.Women's perception of risks of adverse fetal pregnancy outcomes: a large-scale multinational survey.Calcium Channel Blocker Exposure in Late Pregnancy and the Risk of Neonatal Seizures.Promise and peril: Dissemination of findings from studies of drugs used in pregnancy and their association with birth defects.Diagnosing and Treating Depression During Pregnancy.Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta-Analysis of Prospective Cohort Studies Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark.Zidovudine use in pregnancy and congenital malformations.Is third trimester serotonin reuptake inhibitor use associated with postpartum hemorrhage?Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn Maternal serum cadmium level during pregnancy and its association with small for gestational age infants: a population-based birth cohort study.Cardiac dysfunction and prenatal exposure to venlafaxine.Clinical management of medications in pregnancy and lactation.HIV Infection Itself May Not Be Associated With Subclinical Coronary Artery Disease Among African Americans Without Cardiovascular Symptoms Neurotransmitter signaling pathways required for normal development in Xenopus laevis embryos: a pharmacological survey screen Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.The effect of pregestational diabetes on fetal heart function.Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence.The safety of serotonin-noradrenaline reuptake inhibitors (SNRIs) in pregnancy and breastfeeding: a comprehensive review.Use of psychotropic drugs during pregnancy and breast-feeding.First-Trimester Pregnancy Exposure to Venlafaxine or Duloxetine and Risk of Major Congenital Malformations: A Systematic Review.The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.The risks associated with prenatal antidepressant exposure: time for a precision medicine approach.Depression During Pregnancy and Postpartum.Lithium Use in Pregnancy and the Risk of Cardiac Malformations.Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies.

P2860

Q26741187-ABCB9A6A-FADB-41F9-B7C8-0E2928C7034E Q26798225-1C7E110B-DD78-4B89-9DB8-A67E81F0573F Q28069392-9F6C85A8-E0C8-42D3-8641-913E1C915065 Q28385738-6FD37441-39D5-4C51-AFA3-92DEAF3EE697 Q28551620-31939868-A288-48A6-83C9-085BE3CFDC5F Q30244368-22FEFA00-688B-43C2-AAA5-19ECB4F02D6D Q30966054-2F1ED747-CE8A-4D11-BE62-F4912AEDBFB0 Q31126637-A470A0AF-7973-475D-80EB-799F7F687897 Q34047430-49891CC6-9460-40D0-B21F-BE33922F977F Q34240163-F7D692C4-4FB3-401C-B6A7-88C5F4A8F342 Q34483257-9BA2AD5C-57D4-4F61-8B52-DCE005A2E5FC Q34675901-8D188B36-C374-49CD-B185-F3C7DE391FA2 Q34860149-21B1B507-E7E3-482D-8D4D-2382E90DBA84 Q35184473-0DBEBEDA-66CB-4944-BAE9-A2B825AD93C3 Q35541040-78677F99-BE10-488E-AA57-656C503D9E6B Q35691721-65AE4C12-D8A8-4520-B8B5-6B79AFE428D0 Q35919948-83C86E86-C8E0-473E-8483-3CDC82302E33 Q35957458-AA33442A-2DC5-4288-AC86-27606FB96301 Q36028297-170F1919-8B40-4C51-A68E-34EC0D22FE84 Q36141324-505DB7EF-AC91-4175-BD72-C96679A113A7 Q36209588-2235C5DD-4813-4FE6-A251-BCF195848C5B Q36379162-A7A76F4A-1DB8-4307-924D-2032BAA6B237 Q36535314-EDCF4FFE-8220-4946-9C30-4337783E2139 Q36600814-9B212827-040F-48B1-9995-B1ED097BD1C8 Q36645442-A3909083-67C1-4F89-BE8C-F0569F0B5B96 Q36797574-5A82571F-9B2A-49F2-ABDC-ABC294495651 Q36945451-F4F21B0D-9473-45C1-BAE3-530660A240A6 Q37090689-DEEAE981-9F12-4E0F-AE2E-9DD4ACC7E1C9 Q37235692-F4C50819-BDF4-4016-9916-FA9552551944 Q37612128-7459B5E5-314C-4006-AEB0-8AA536387EFB Q38272291-9BAD0EA1-D656-4950-8416-3A1640B94827 Q38305749-C51B67C6-8624-46B5-AC4F-ED752F710656 Q38382317-D628E2C9-8C4F-426D-AB77-17D55AFBCA4C Q38582061-7DF5098A-1A01-4EE4-AA03-0E8C771C3176 Q38599005-12D5C55F-FBF6-4785-89A4-4C612E7BB760 Q38672603-2C69DCE5-3D1C-431B-935B-BBFE33E32CC9 Q38722632-0BB71BC5-33D2-459A-97EC-B894D2D8F025 Q38734781-D98630C1-4FED-40C7-B199-FBB276302ED7 Q38738035-85B67979-BAA1-4239-80D0-DF450B7ADE78 Q38781285-D7242C35-1D1F-43EE-B356-82273529A6EA

P2860

Antidepressant use in pregnancy and the risk of cardiac defects

http://www.wikidata.org/entity/Q33775616

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antidepressant use in pregnancy and the risk of cardiac defects

@ast

Antidepressant use in pregnancy and the risk of cardiac defects

@en

type

label

Antidepressant use in pregnancy and the risk of cardiac defects

@ast

Antidepressant use in pregnancy and the risk of cardiac defects

@en

prefLabel

Antidepressant use in pregnancy and the risk of cardiac defects

@ast

Antidepressant use in pregnancy and the risk of cardiac defects

@en

P1433

Q33775616-11D7FADC-6610-4FA8-A649-314B65768CEE

P1476

Q33775616-F64133CA-1220-4B7D-AAC8-E2328EE468C7

P2093

Q33775616-0D6D6B8A-92F1-4D59-941D-65EB41DD4F3C

Q33775616-43822B5A-71E7-4549-92FF-C825C0EDACC4

Q33775616-65E75868-9EE4-4E1C-900A-48600B183231

Q33775616-7E1A64AC-7BF4-4B8D-8775-0082C4ED8C8F

Q33775616-9E28E542-659D-4160-8D89-3F0F80CA3CD7

Q33775616-A338EEC1-85B1-44D8-B752-B053E5B64C59

Q33775616-AA179F42-FF52-4714-8C06-CA069734AD2F

Q33775616-AF670771-19ED-4589-B866-09E745AE2012

Q33775616-D5991A17-176E-4BE4-92DD-B8CF73E4CD08

Q33775616-E2804E9D-C259-49EE-B2D0-95B46CFC9250

P2860

Q33775616-0085E9E7-24DC-4F6E-BD2C-3106214F1BDE

Q33775616-11522E33-2D33-4A96-9F79-22C593920EAA

Q33775616-1365CA16-D832-4C56-AFCA-56EBC1E9E79F

Q33775616-1B43AEF9-4BD9-4123-B164-07974F43C2C4

Q33775616-23725081-0784-497E-A0E4-199D153CE157

Q33775616-23F00FD1-6074-43F8-8ED3-316C3C09BFFD

Q33775616-3E8090C4-A05E-4C7D-9D45-823F86D1E74A

Q33775616-3F4F3A32-B84A-4AB5-97DB-B579CBDC080A

Q33775616-4AFAB9F7-C7F6-49D6-8313-D2CB1DAF147F

Q33775616-511F4D25-D8E4-44C3-9F96-49E7A8285904

P304

Q33775616-785A665F-B48F-4DB5-8A6E-F58451534124

P31

Q33775616-CD900CFA-7401-4E67-A829-D49E2BC10B09

P356

Q33775616-78BF6368-A39F-4977-8F9D-204548E0C2FC

P407

Q33775616-2EAFFB30-B7BE-4871-B90E-0FACD764DB73

P433

Q33775616-9B9565E1-6975-4772-B31B-3376E3617751

P478

Q33775616-AE824892-7150-4122-ABF5-0265A993FD08

P577

Q33775616-F530B0AC-EBEB-4911-BB7C-24102D3EFD5C

P698

Q33775616-355BFA9B-E863-48BD-BCC7-29E9E65C197E

P932

Q33775616-0B86263F-8762-426F-A5E8-94D12A41FC1F

P356

P1433

The New England Journal of Medicine

P1476

Antidepressant use in pregnancy and the risk of cardiac defects

@en

P2093

Helen Mogun

http://www.w3.org/2001/XMLSchema#string

Jerry Avorn

http://www.w3.org/2001/XMLSchema#string

Jessica M Franklin

http://www.w3.org/2001/XMLSchema#string

Krista F Huybrechts

http://www.w3.org/2001/XMLSchema#string

Kristin Palmsten

http://www.w3.org/2001/XMLSchema#string

Lee S Cohen

http://www.w3.org/2001/XMLSchema#string

Lewis B Holmes

http://www.w3.org/2001/XMLSchema#string

Mary Kowal

http://www.w3.org/2001/XMLSchema#string

Raisa Levin

http://www.w3.org/2001/XMLSchema#string

Soko Setoguchi

http://www.w3.org/2001/XMLSchema#string

P2860

Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data.

Validity of maternal and infant outcomes within nationwide Medicaid data.

Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data.

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data

National trends in antidepressant medication treatment among publicly insured pregnant women

Risks associated with selective serotonin reuptake inhibitors in pregnancy.

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

P304

2397-2407

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1312828

http://www.w3.org/2001/XMLSchema#string

P407

P433

25

http://www.w3.org/2001/XMLSchema#string

P478

370

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24941178

http://www.w3.org/2001/XMLSchema#string

P932

4062924

http://www.w3.org/2001/XMLSchema#string